Wayne Winegarden
Blog
Proxy Advisory Firms Are Worsening CalPERS and CalSTRS ESG Problem
My last blog post discussed the risks that ESG investing creates for CalPERS and CalSTRS. If not addressed, then both taxpayers and public employees will bear unnecessary costs and risks. Unfortunately, SEC rules are making this problem even worse. The SEC requires all institutional investors, such as CalPERS and CalSTRS, ...
Business & Economics
New Study Shows California/New York Approach to Fighting Global Warming Hurts Working Class and Minority Communities
Legislating Energy Poverty Shows Market-Based Policies More Effective in Cutting Emissions The big government approach to fighting ‘global warming’ taken by California and New York hits working class and minority communities the hardest, a new report released today by the California-based free-market think tank, the Pacific Research Institute, concludes. “Overzealous ...
Blog
The ESG Threat to California’s Pensions
California’s public pensions are in trouble. While the Pew Charitable Trusts reports that California’s current unfunded liabilities are nearly $170 billion, as I recently reported in my chartbook on California’s pension crisis, the crisis is much worse. Valuing the liabilities using a more realistic market rate, the total pension debt ...
Business & Economics
Redefining Presidential Failure As Success
While success still has many fathers, failure is no longer an orphan. President Obama’s recent speeches and rallies demonstrate that, now, failure is simply redefined as success. The costs from this revisionism is high. Creating false narratives encourage policies that will harm economic prosperity and impose large economic hardships on ...
Business & Economics
The Bizarre World of Drug Pricing
There is no shortage of bad ideas when it comes to the pharmaceutical market. One such proposal would allow drugs to be imported directly from other countries, such as Canada. Then there is the Trump Administration’s proposal that would effectively adopt foreign price controls on Medicare Part B drugs by ...
Business & Economics
New Medicare Price Controls Don’t Put America First
Health and Human Services Secretary Alex Azar just released a sweeping proposal that would drastically change how Medicare pays for advanced cancer therapies and other potent medicines. The plan relies on foreign price controls to reduce drug spending by $17 billion over five years. Although drug spending may decline, as ...
Business & Economics
The Law of Unintended Consequences: The Case of Proxy Advisory Firms
The SEC requires all institutional investors to vote on all matters put forth in proxy statements, or the measures voted on during shareholder meetings. For most institutional investors, keeping up with all of these issues is not feasible, so they turn to proxy advisory firms. Proxy advisory firms help institutional ...
Blog
Does President Trump Favor Price Controls?
At 2 pm Eastern time today, President Trump spoke at the Department of Health and Human Services where he recommended a litany of policies that would ultimately impose price controls on the pharmaceutical market. Take his proposal to force the prices paid by Medicare for drugs administer in doctors’ offices ...
Business & Economics
Repeal the Medical Device Tax
Rarely is there bipartisan agreement that a tax cut won’t cost the federal government money. But, in the case of the medical device tax (a 2.3 percent tax on medical devices and products that was passed as part of the Affordable Care Act) this is true by definition because the ...
Business & Economics
The benefits of repealing the medical device tax
As part of the Affordable Care Act, a 2.3 percent tax on medical devices and products was passed. The tax was levied on devices such as pacemakers, advanced imaging technologies (Cat Scan, MRI and ultrasound equipment), artificial joints, surgical gloves, and dental instruments. Devices that the public generally buys for ...
Proxy Advisory Firms Are Worsening CalPERS and CalSTRS ESG Problem
My last blog post discussed the risks that ESG investing creates for CalPERS and CalSTRS. If not addressed, then both taxpayers and public employees will bear unnecessary costs and risks. Unfortunately, SEC rules are making this problem even worse. The SEC requires all institutional investors, such as CalPERS and CalSTRS, ...
New Study Shows California/New York Approach to Fighting Global Warming Hurts Working Class and Minority Communities
Legislating Energy Poverty Shows Market-Based Policies More Effective in Cutting Emissions The big government approach to fighting ‘global warming’ taken by California and New York hits working class and minority communities the hardest, a new report released today by the California-based free-market think tank, the Pacific Research Institute, concludes. “Overzealous ...
The ESG Threat to California’s Pensions
California’s public pensions are in trouble. While the Pew Charitable Trusts reports that California’s current unfunded liabilities are nearly $170 billion, as I recently reported in my chartbook on California’s pension crisis, the crisis is much worse. Valuing the liabilities using a more realistic market rate, the total pension debt ...
Redefining Presidential Failure As Success
While success still has many fathers, failure is no longer an orphan. President Obama’s recent speeches and rallies demonstrate that, now, failure is simply redefined as success. The costs from this revisionism is high. Creating false narratives encourage policies that will harm economic prosperity and impose large economic hardships on ...
The Bizarre World of Drug Pricing
There is no shortage of bad ideas when it comes to the pharmaceutical market. One such proposal would allow drugs to be imported directly from other countries, such as Canada. Then there is the Trump Administration’s proposal that would effectively adopt foreign price controls on Medicare Part B drugs by ...
New Medicare Price Controls Don’t Put America First
Health and Human Services Secretary Alex Azar just released a sweeping proposal that would drastically change how Medicare pays for advanced cancer therapies and other potent medicines. The plan relies on foreign price controls to reduce drug spending by $17 billion over five years. Although drug spending may decline, as ...
The Law of Unintended Consequences: The Case of Proxy Advisory Firms
The SEC requires all institutional investors to vote on all matters put forth in proxy statements, or the measures voted on during shareholder meetings. For most institutional investors, keeping up with all of these issues is not feasible, so they turn to proxy advisory firms. Proxy advisory firms help institutional ...
Does President Trump Favor Price Controls?
At 2 pm Eastern time today, President Trump spoke at the Department of Health and Human Services where he recommended a litany of policies that would ultimately impose price controls on the pharmaceutical market. Take his proposal to force the prices paid by Medicare for drugs administer in doctors’ offices ...
Repeal the Medical Device Tax
Rarely is there bipartisan agreement that a tax cut won’t cost the federal government money. But, in the case of the medical device tax (a 2.3 percent tax on medical devices and products that was passed as part of the Affordable Care Act) this is true by definition because the ...
The benefits of repealing the medical device tax
As part of the Affordable Care Act, a 2.3 percent tax on medical devices and products was passed. The tax was levied on devices such as pacemakers, advanced imaging technologies (Cat Scan, MRI and ultrasound equipment), artificial joints, surgical gloves, and dental instruments. Devices that the public generally buys for ...
